Aspira Womens Health Stock Alpha and Beta Analysis
| AWH Stock | USD 0.81 0.05 6.58% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aspira Womens Health. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aspira Womens over a specified time horizon. Remember, high Aspira Womens' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aspira Womens' market risk premium analysis include:
Beta 1.07 | Alpha (0.39) | Risk 4.95 | Sharpe Ratio (0.04) | Expected Return (0.19) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Aspira |
Aspira Womens Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aspira Womens market risk premium is the additional return an investor will receive from holding Aspira Womens long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aspira Womens. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aspira Womens' performance over market.| α | -0.39 | β | 1.07 |
Aspira Womens expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Aspira Womens' Buy-and-hold return. Our buy-and-hold chart shows how Aspira Womens performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Aspira Womens Market Price Analysis
Market price analysis indicators help investors to evaluate how Aspira Womens stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aspira Womens shares will generate the highest return on investment. By understating and applying Aspira Womens stock market price indicators, traders can identify Aspira Womens position entry and exit signals to maximize returns.
Aspira Womens Return and Market Media
The median price of Aspira Womens for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 0.85 with a coefficient of variation of 10.0. The daily time series for the period is distributed with a sample standard deviation of 0.09, arithmetic mean of 0.86, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Parnell Winfred of 3268 shares of Aspira Womens at 1.53 subject to Rule 16b-3 | 09/19/2024 |
2 | Acquisition by Sharma Ruby of 35115 shares of Aspira Womens subject to Rule 16b-3 | 09/27/2024 |
3 | Disposition of 5000 shares by Fralick Celeste Rachelle of Aspira Womens subject to Rule 16b-3 | 09/30/2024 |
4 | Acquisition by Fralick Celeste Rachelle of 5000 shares of Aspira Womens subject to Rule 16b-3 | 10/02/2024 |
5 | Aspira Womens Health Receives Approval from New York State Department of Health for OvaWatch | 10/15/2024 |
6 | Aspira Womens Health faces Nasdaq delisting over share price - Investing.com | 10/18/2024 |
7 | AWH Stock Plummets 6.19 percent Amid Weak Financial Performance | 10/25/2024 |
8 | Acquisition by Sandford Nicole of 25000 shares of Aspira Womens subject to Rule 16b-3 | 10/28/2024 |
9 | Acquisition by Jordan Veronica Gh of 7045 shares of Aspira Womens subject to Rule 16b-3 | 10/29/2024 |
10 | Aspira Womens Health Expands Co-Marketing and Distribution Collaboration with BioReference to Include OvaWatch | 11/07/2024 |
11 | AWH ANNOUNCES Q3 2024 FINANCIAL RESULTS | 11/12/2024 |
12 | Aspira Womens Health Reports Selected Third Quarter 2024 Financial Results | 11/14/2024 |
13 | Aspira Womens Health Inc Q3 2024 Earnings Call Highlights Strategic Wins Amidst Market ... | 11/15/2024 |
About Aspira Womens Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aspira or other stocks. Alpha measures the amount that position in Aspira Womens Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Dividend Yield | 0.009857 | 0.009364 | Price To Sales Ratio | 4.12 | 3.91 |
Aspira Womens Upcoming Company Events
As portrayed in its financial statements, the presentation of Aspira Womens' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aspira Womens' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aspira Womens' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aspira Womens. Please utilize our Beneish M Score to check the likelihood of Aspira Womens' management manipulating its earnings.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Aspira Womens
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Aspira Womens Backtesting, Aspira Womens Valuation, Aspira Womens Correlation, Aspira Womens Hype Analysis, Aspira Womens Volatility, Aspira Womens History and analyze Aspira Womens Performance. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Aspira Womens technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.